(MedPage Today) -- Short-term estrogen therapy induced cellular changes in urothelium consistent with improved ability to fight off urinary tract infection, results from clinical and preclinical studies suggested.
SAN FRANCISCO (MedPage Today) -- The Endocrine Society has joined its voice to the recent call for incretin drugmakers to release all patient-level data on their products, the group announced at its annual meeting.
(MedPage Today) -- Saxagliptin (Onglyza) was no better than placebo at reducing major cardiovascular events in a large trial of high-risk patients with type 2 diabetes, according to the companies selling the drug in the U.S.
(MedPage Today) -- Obesity had a mixed effect on outcomes after percutaneous coronary intervention, conferring an increased mortality risk only after adjustment for potential confounders, analysis of a large database showed.
SAN FRANCISCO (MedPage Today) -- Giving testosterone to men with type 2 diabetes who are deficient in the hormone improved their insulin sensitivity, researchers reported here.
SAN FRANCISCO (MedPage Today) -- Patients with diabetes have poorer outcomes following a lung transplant, researchers reported here.
SAN FRANCISCO (MedPage Today) -- Levels of free thyroxine at the higher end of the normal range are associated with all-cause mortality in older men who do not have thyroid disease, researchers found.
SAN FRANCISCO (MedPage Today) -- Teens and young adults with type 2 diabetes who have low vitamin D levels appear to be at risk for arterial stiffness, a signal of increased cardiovascular risk, researchers found.
SAN FRANCISCO (MedPage Today) -- Adding the diabetes drug liraglutide (Victoza) to metformin might be beneficial for obese women with polycystic ovary syndrome (PCOS), a pilot study showed.
(MedPage Today) -- Multiple autoantibodies against pancreatic beta cells predict progression to type 1 diabetes within a decade for most high-risk kids, longitudinal cohorts showed.